Efficacy of using corticosteroids as adjunctive therapy in septic shock

Authors

DOI:

https://doi.org/10.47456/bjpe.v8i1.37280

Keywords:

Efficiency, Corticosteroids, Therapy, Septic shock

Abstract

Context: Septic shock is a state of acute circulatory failure combined with an infectious focus or with a predominance of an endotoxic component. Corticosteroid therapy has been used with the main focus on hypoperfusion. Corticosteroids are a class of drugs synthesized on the basis of endocrine steroid hormones, which are produced and secreted by the cortex of the adrenal glands. However, the efficacy and safety of corticosteroid therapy in septic shock remains uncertain, as there are both reports of clinical improvement and serious adverse effects, such as superinfection and metabolic and neuromuscular effects. Objective: Given the above, the present study aims to evaluate the effectiveness of adjuvant therapy with corticosteroids in patients with septic shock in order to look for scientific evidence showing benefits of this treatment, as well as to establish, if positive, the management of according to the evidence, of corticosteroids in this pathology. Method: It is characterized as an Integrative Review, in which the articles were selected on the Virtual Health Library platform, in which 460 articles were identified, but after applying the filters and selection criteria, 39 were selected among them. Results: The country that was the target of studies on such behavior was the United States. These studies were carried out more frequently in 2017, 2018 and 2019. After analyzing the data, it was suggested that this therapy was related to a faster reversal of shock and a reduction in the days of vasopressor use, in addition to decreasing the length of stay in the ICU. However, there are risks of adverse effects. Conclusion: Therefore, it was concluded that patients who are candidates for this treatment are those with greater severity and/or who do not respond primarily to resuscitation with fluids and vasoactive drugs. Furthermore, the use of these medications must be individualized, considering.

Downloads

Author Biographies

Wellington Felipe Leite, Faculdades Integradas de Patos, FIP, Brasil

Graduating in Medicine at the University Center of Patos - UNIFIP. Vice-President and effective member of the Academic League of Surgical Clinic of the Centro Universitário de Patos - LACC-UNIFIP. Vice-President and effective member of the Academic League of Orthopedics and Traumatology of Faculdades Integradas de Patos - LAOT-FIP. Member of the Academic League of Family and Community Medicine of the Centro Universitário de Patos (LAMFAC-UNIFIP). Member of the research and extension project A-COR-DAR. Member of the International Federation of Medical Students Associations - IFMSA. (Text provided by the author)

Osman Batista de Medeiros Filho, Centro Universitário de Patos - UNIFIP

Graduated in Medicine from the Federal University of Paraíba (2012) and Residency in Internal Medicine at the Hospital das Clínicas of the Federal University of Pernambuco (2016). He works as a clinician and coordinator of the UFCG Health Care Center and as a clinician at the Alcides Carneiro University Hospital (HUAC) by Ebserh. He also works as Supervisor of the Mais Médicos Program at UFCG, performs the functions of Coordinator and preceptor of the Internal Medicine Internship at UNIFIP, professor of Gastroenterology at UNIFIP and preceptor of the Internal Medicine Residency at SMS Patos-PB. (Text provided by the author)

Milena Nunes Alves de Sousa, Centro Universitário de Patos - UNIFIP

Paraibana, daughter of Conceição, hinterland of Paraíba. Tourismologist from the Faculty of Applied Social Sciences (2004), Administrator from the State University of Paraíba (2007), Nurse from the Faculty of Campina Grande (2008), Master in Health Sciences from the Cruzeiro do Sul University (2009), Doctor in Health Promotion from the University of Franca (2014), Post-Doctorate in Health Promotion from the University of Franca (2016) and Post-Doctorate in Agroindustrial Systems from the Federal University of Campina Grande (2018). She is currently a professor at the Centro Universitário de Patos (UNIFIP), on a full-time basis. He has experience in the areas of Administration and Health, working mainly on the following topics: health promotion, environment and work, health and environment, aging and health, quality of life, health management and planning. She is currently Dean of Research, Extension and Graduate Studies at UNIFIP, Coordinator of the Investigative Practices in Health Axis and of the Course Completion Work of the Medicine Course at UNIFIP. She is a researcher in the research group: Seniors: behavior, gender and lifestyle. Orcid: 0000-0001-8327-9147. (Text provided by the author)

References

Allen, J. M., Feild, C., Shoulders, B. R., & Voils, S. A. (2019). Recent updates in the pharmacological management of sepsis and septic shock: a systematic review focused on fluid resuscitation, vasopressors, and corticosteroids. Annals of Pharmacotherapy, 53(4), 385-395. https://doi.org/10.1177/1060028018812940

Angurana, S. K. & Kumar, P. (2017). Assessing feasibility of randomized controlled trials of corticosteroids in pediatric septic shock in developed countries: only half the answer to the problem. Pediatric Critical Care Medicine, 18(11), 1087. https://doi.org/10.1097/PCC.0000000000001310

Annane, D. (2019). Why my steroid trials in septic shock were “positive”. Critical care medicine, 47(12), 1789-1793. https://doi.org/10.1097/CCM.0000000000003889

Antcliffe, D. B. & Gordon, A. C. (2019). Why understanding sepsis endotypes is important for steroid trials in septic shock. Critical care medicine, 47(12), 1782-1784. https://doi.org/10.1097/CCM.0000000000003833

Argent, A. C. & Kissoon, N. (2017). Randomized Clinical Trials of Corticosteroids in Septic Shock: Possibly Feasible, But Will They or Should They Change My Practice? Pediatric critical care medicine, 18(6), 589-590. https://doi.org/10.1097/PCC.0000000000001138

Bentzer, P., Fjell, C., Walley, K. R., Boyd, J., & Russell, J. A. (2016). Plasma cytokine levels predict response to corticosteroids in septic shock. Intensive care medicine, 42(12), 1970-1979. https://doi.org/10.1007/s00134-016-4338-z

Briegel, J., Bein, T., & Möhnle, P. (2017). Update on low-dose corticosteroids. Current Opinion in Anesthesiology, 30(2), 186-191. https://doi.org/10.1097/ACO.0000000000000442

Cecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018). Sepsis and septic shock. The Lancet, 392(10141), 75-87. https://doi.org/10.1016/S0140-6736(18)30696-2

Cohen, J., & Venkatesh, B. (2019). Adjunctive corticosteroid treatment in septic shock. Anesthesiology, 131(2), 410-419. https://doi.org/10.1097/ALN.0000000000002604

Costanzo, L. S. (2018). Fisiologia. 6. ed. Rio de Janeiro: Elsevier Editora Ltda.

Cvijanovich, N. Z., Anas, N., Allen, G. L., Thomas, N. J., Bigham, M. T., Weiss, S. L., ... & Wong, H. R. (2017). Glucocorticoid receptor polymorphisms and outcomes in pediatric septic shock. Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 18(4), 299. https://doi.org/10.1097/PCC.0000000000001058

Darmaros, L. F., Delgado, A. F., & Carvalho, W. B. D. (2016). Corticosteroids in septic shock: What should the decision in pediatrics be? Revista da Associação Médica Brasileira, 62, 482-484. https://doi.org/10.1590/1806-9282.62.06.482

El-Nawawy, A., Khater, D., Omar, H., & Wali, Y. (2017). Evaluation of early corticosteroid therapy in management of pediatric septic shock in pediatric intensive care patients: a randomized clinical study. The Pediatric infectious disease journal, 36(2), 155-159. https://doi.org/10.1097/INF.0000000000001380

Fang, F., Zhang, Y., Tang, J., Lunsford, L. D., Li, T., Tang, R., ... & You, C. (2019). Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis. JAMA internal medicine, 179(2), 213-223. https://doi.org/10.1001/jamainternmed.2018.5849

Garza, M. I., Zapata, M. P., Bilbao, I. G., Martínez, C. F., Horno, R. A., & Pomes, G. G. (2018). Administración de corticoides a los pacientes con sepsis grave y mejora de su mortalidad intrahospitalaria: Una revisión sistemática. Enfermería Global, 17(4), 612-639. https://doi.org/10.6018/eglobal.17.4.321571

Gibbison, B., López-López, J. A., Higgins, J. P., Miller, T., Angelini, G. D., Lightman, S. L., & Annane, D. (2017). Corticosteroids in septic shock: a systematic review and network meta-analysis. Critical Care, 21(1), 1-8. https://doi.org/10.1186/s13054-017-1659-4

Golan, D.E., Tashjian, A.H., Armstrong, E.J., & Armstrong, A.W. (2018). Princípios de farmacologia: a base fisiopatológica da farmacoterapia. 3. ed. Rio de Janeiro: Guanabara Koogan.

Hall, J.E. & Guyton, A.C. (2017). Guyton e Hall fundamentos da fisiologia. 13. ed. Rio de Janeiro: Elsevier Editora Ltda.

Hyvernat, H., Doyen, D., Barel, R., Kaidomar, M., Goubaux, B., Pradier, C., ... & Bernardin, G. (2018). Is inappropriate response to cosyntropin stimulation test an indication of corticosteroid resistance in septic shock? Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, 49(5), 543-550. https://doi.org/10.1097/SHK.0000000000001014

Instituto Latino Americano de Sepse (ILAS) (2018). Implementação de protocolo gerenciado de sepse protocolo clínico: Atendimento ao paciente adulto com sepse/choque séptico. São Paulo: ILAS. 14p. Recuperado de https://www.hcrp.usp.br/revistaqualidadehc/edicaoselecionada.aspx?Edicao=6

Ismail, J. & Jayashree, M. (2018). Advances in the Management of Pediatric Septic Shock: Old Questions, New Answers. Indian pediatrics, 55(4).

Jorge, R. L. N., Lourenço, L. A., Vieira, L. H. D. A., Santana, M. N., & Pedroso, E. R. P. (2016). Choque séptico. Rev Med Minas Gerais, 26(4), 9-12. https://doi.org/10.5935/2238-3182.20160040

Law, A. C., Sahetya, S., Walkey, A. J., & Delaney, A. (2018). Low-dose corticosteroids and septic shock resolution: implications for randomized trial design? Intensive care medicine, 44(8), 1366-1367. https://doi.org/10.1007/s00134-018-5265-y

Lee, C. T., & Yeh, Y. C. (2018). The role of corticosteroid in septic shock patients: The authors reply. Journal of critical care, 43, 386. https://doi.org/10.1016/j.jcrc.2017.11.016

Lemieux, S. M., Levine, A. R., & Gritsenko, D. (2019). Was Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock (ADRENAL) Insufficient? Critical care medicine, 47(12), e1035-e1035. https://doi.org/10.1097/ccm.0000000000003980

Lian, X. J., Huang, D. Z., Cao, Y. S., Wei, Y. X., Lian, Z. Z., Qin, T. H., ... & Wang, S. H. (2019). Reevaluating the role of corticosteroids in septic shock: an updated meta-analysis of randomized controlled trials. BioMed research international. https://doi.org/10.1155/2019/3175047

Liu, A., & Menon, K. (2018). Contributions of a survey and retrospective cohort study to the planning of a randomised controlled trial of corticosteroids in the treatment of paediatric septic shock. Trials, 19(1), 1-8. https://doi.org/10.1186/s13063-018-2664-x

Long, B., & April, M. D. (2018). Do corticosteroids improve mortality or shock reversal in patients with septic shock? Annals of Emergency Medicine, 71(1), 34-36. https://doi.org/10.1016/j.annemergmed.2017.05.025

Long, B., & Koyfman, A. (2017). Controversies in corticosteroid use for sepsis. The Journal of emergency medicine, 53(5), 653-661. https://doi.org/10.1016/j.jemermed.2017.05.024

Mendes, K. D. S., Silveira, R. C. D. C. P., & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & contexto-enfermagem, 17, 758-764. https://doi.org/10.1590/S0104-07072008000400018

Menon, K., & McNally, J. D. (2018). Corticosteroids in pediatric septic shock are helpful. Critical care medicine, 46(4), 635-636. https://doi.org/10.1097/CCM.0000000000002979

Meyer, E. J., Nenke, M. A., Rankin, W., Lewis, J. G., Konings, E., Slager, M., ... & Torpy, D. J. (2019). Total and high‐affinity corticosteroid‐binding globulin depletion in septic shock is associated with mortality. Clinical endocrinology, 90(1), 232-240. https://doi.org/10.1111/cen.13844

Moskowitz, A., Yankama, T., Andersen, L. W., Huang, D. T., Donnino, M. W., & Grossestreuer, A. V. (2019). Ascorbic Acid, Corticosteroids and Thiamine in Sepsis (ACTS) protocol and statistical analysis plan: a prospective, multicentre, double-blind, randomised, placebo-controlled clinical trial. BMJ open, 9(12), e034406. https://doi.org/10.1136/bmjopen-2019-034406

O’Hearn, K., McNally, D., Choong, K., Acharya, A., Wong, H. R., Lawson, M., ... & Menon, K. (2016). Steroids in fluid and/or vasoactive infusion dependent pediatric shock: study protocol for a randomized controlled trial. Trials, 17(1), 1-10. https://doi.org/10.1186/s13063-016-1365-6

Pourmand, A., Whiteside, T., Yamane, D., Rashed, A., & Mazer-Amirshahi, M. (2019). The controversial role of corticosteroids in septic shock. The American journal of emergency medicine, 37(7), 1353-1361. https://doi.org/10.1016/j.ajem.2019.04.045

Ramamoorthy, S., & Cidlowski, J. A. (2016). Corticosteroids: mechanisms of action in health and disease. Rheumatic Disease Clinics, 42(1), 15-31. https://doi.org/10.1016/j.rdc.2015.08.002

Ramanan, M., Cohen, J., & Venkatesh, B. (2019). Steroids and Sepsis: the Debate Continues. International anesthesiology clinics, 57(2), 17-30. https://doi.org/10.1097/AIA.0000000000000220

Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., ... & Dellinger, R. P. (2017). Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive care medicine, 43(3), 304-377. https://doi.org/10.1007/s00134-017-4683-6

Ritter, J.M., Flower, R., Henderson, G., Loke, Y.k., MacEwan, D., & Rang, H.P. (2020) Rang & Dale: farmacologia. 9. ed. Rio de Janeiro: Guanabara Koogan.

Russell, J. A. (2018). When and how to use predictive biomarkers for corticosteroid treatment of septic shock. Critical Care, 22(1), 1-3. https://doi.org/10.1186/s13054-018-2254-z

Russell, J. A., & Sevransky, J. (2019). Toward increased understanding of the steroid controversy in septic shock. Critical care medicine, 47(12), 1677-1679. https://doi.org/10.1097/CCM.0000000000004038

Salluh, J. I., & Póvoa, P. (2017). Corticosteroids in severe sepsis and septic shock: a concise review. Shock, 47(1S), 47-51. https://doi.org/10.1097/SHK.0000000000000704

Seymour, C. W., & Rosengart, M. R. (2015). Septic shock: advances in diagnosis and treatment. Jama, 314(7), 708-717. https://doi.org/10.1001/jama.2015.7885

Souza, M. T. D., Silva, M. D. D., & Carvalho, R. D. (2010). Revisão integrativa: o que é e como fazer. Einstein (São Paulo), 8, 102-106. https://doi.org/10.1590/S1679-45082010RW1134

Venkatesh, B., & Cohen, J. (2019). Why the adjunctive corticosteroid treatment in critically Ill patients with septic shock (ADRENAL) trial did not show a difference in mortality. Critical care medicine, 47(12), 1785-1788. https://doi.org/10.1097/CCM.0000000000003834

Wen, Y., Zhu, Y., Jiang, Q., Guo, N., Cai, Y., & Shen, X. (2019). The effectiveness and safety of corticosteroids therapy in adult critical ill patients with septic shock: a meta-analysis of randomized controlled trials. Shock, 52(2), 198-207. https://doi.org/10.1097/SHK.0000000000001202

Wong, H. R., Atkinson, S. J., Cvijanovich, N. Z., Anas, N., Allen, G. L., Thomas, N. J., ... & Lindsell, C. J. (2016). Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids. Critical care medicine, 44(10), e1000. https://doi.org/10.1097/CCM.0000000000001833

Yang, J., & Sun, S. (2020). Controversies in the application of corticosteroids for pediatric septic shock treatment: a preferred reporting items for systematic reviews and meta-analysis-compliant updated meta-analysis. Medicine, 99(30). https://doi.org/10.1097/MD.0000000000020762

Zhou, X., Ye, Y., Li, J., & Tang, G. (2018). The role of corticosteroid in septic shock patients. Journal of critical care, 43, 384-385. https://doi.org/10.1016/j.jcrc.2017.11.015

Zimmerman, J. J. (2016). Adjunctive Corticosteroids for Contemporary Pediatric Shock: Ongoing Analysis of the Risk-Benefit Ratio. The Journal of pediatrics, 177, 9-11.:https://doi.org/10.1016/j.jpeds.2016.06.039

Zimmerman, J. J. (2018). Corticosteroids in pediatric septic shock are not helpful. Critical care medicine, 46(4), 637. https://doi.org/10.1097/CCM.0000000000002980

Downloads

Published

2022-02-22

How to Cite

Leite, W. F., Medeiros Filho, O. B. de, & Sousa, M. N. A. de. (2022). Efficacy of using corticosteroids as adjunctive therapy in septic shock. Brazilian Journal of Production Engineering, 8(1), 92–106. https://doi.org/10.47456/bjpe.v8i1.37280

Issue

Vol. 8 No. 1 (2022): Número Regular (Janeiro - Março)

Section

TECHNOLOGY AND INNOVATION IN HEALTH

License

Copyright (c) 2022 Brazilian Journal of Production Engineering - BJPE

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Atribuição 4.0 internacional CC BY 4.0 Deed